This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975;10(5-6):336-41.

doi: 10.2165/00003495-197510050-00003.

Problems with practolol

H J Wall-Manning

PMID: 1240
DOI: 10.2165/00003495-197510050-00003

Problems with practolol

H J Wall-Manning. Drugs. 1975.

. 1975;10(5-6):336-41.

doi: 10.2165/00003495-197510050-00003.

Author

H J Wall-Manning

PMID: 1240
DOI: 10.2165/00003495-197510050-00003

No abstract available

PubMed Disclaimer

Similar articles

Adverse reaction to the beta-adrenergic blocking drugs.
Brigden WD, Almeyda J. Brigden WD, et al. Br J Dermatol. 1976 Sep;95(3):335-8. doi: 10.1111/j.1365-2133.1976.tb07026.x. Br J Dermatol. 1976. PMID: 974021 No abstract available.
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Frishman W, Silverman R, Strom J, Elkayam U, Sonnenblick E. Frishman W, et al. Am Heart J. 1979 Aug;98(2):256-62. doi: 10.1016/0002-8703(79)90229-1. Am Heart J. 1979. PMID: 36744 No abstract available.
Beta-adrenoceptor blocking drugs: adverse reactions and drug interactions.
Kendall MJ, Beeley L. Kendall MJ, et al. Pharmacol Ther. 1983;21(3):351-69. doi: 10.1016/0163-7258(83)90060-8. Pharmacol Ther. 1983. PMID: 6138787 Review.
Eye and skin reactions precede practolol peritonitis.
Idänpään-Heikkilä JE, Hästbacka J, Järvinen HJ. Idänpään-Heikkilä JE, et al. Lancet. 1977 Dec 24-31;2(8052-8053):1354. doi: 10.1016/s0140-6736(77)90397-x. Lancet. 1977. PMID: 74720 No abstract available.
[Betablockers and skin (author's transl)].
Bonnetblanc JM, Roux J. Bonnetblanc JM, et al. Ann Dermatol Venereol. 1979 Nov;106(11):927-30. Ann Dermatol Venereol. 1979. PMID: 44166 Review. French.

See all similar articles

Cited by

Comparison of methods to detect side-effect on clinical application of chloranolol, a beta-adrenergic receptor inhibitor.
Török E, Kósa E, Szontagh M, Juvancz P, Eggenhofer J, Borvendég J. Török E, et al. Eur J Clin Pharmacol. 1984;26(5):555-62. doi: 10.1007/BF00543484. Eur J Clin Pharmacol. 1984. PMID: 6147256 Clinical Trial.
Antinuclear antibodies and cardiovascular drugs.
Wilson JD. Wilson JD. Drugs. 1980 Apr;19(4):292-305. doi: 10.2165/00003495-198019040-00004. Drugs. 1980. PMID: 6103797 Review.
Irreversible protein binding of [14C]-practolol metabolite(s) to hamster liver microsomes (proceedings).
Orton TC, Lowery C, Lindup WE. Orton TC, et al. Br J Pharmacol. 1977 Jun;60(2):319P. Br J Pharmacol. 1977. PMID: 880481 Free PMC article. No abstract available.
Endralazine, a new peripheral vasodilator. Evaluation of safety and efficacy over a 3 year period.
Bogers WA, Meems L. Bogers WA, et al. Eur J Clin Pharmacol. 1983;24(3):301-5. doi: 10.1007/BF00610045. Eur J Clin Pharmacol. 1983. PMID: 6861845
Adverse reactions to practolol in hospitalized patients: a report from the Boston Collaborative Drug Surveillance Program.
Pfeifer HJ, Greenblatt DJ, Koch-Weser J. Pfeifer HJ, et al. Eur J Clin Pharmacol. 1977 Nov 14;12(3):167-70. doi: 10.1007/BF00609854. Eur J Clin Pharmacol. 1977. PMID: 590302

See all "Cited by" articles

References

1. Br Med J. 1975 May 24;2(5968):443 - PubMed
1. Br Med J. 1974 Nov 30;4(5943):528 - PubMed
1. Br Med J. 1975 Mar 15;1(5958):598-600 - PubMed
1. Br Med J. 1975 May 31;2(5969):498 - PubMed
1. Br Med J. 1975 Mar 15;1(5958):595-8 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Springer